Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Capital Expenditures: 2018-2024

Historic Capital Expenditures for Therapeutics (RAPT) over the last 7 years, with Dec 2024 value amounting to $122,000.

  • Therapeutics' Capital Expenditures fell 98.51% to $1,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $122,000, marking a year-over-year decrease of 89.16%. This contributed to the annual value of $122,000 for FY2024, which is 89.16% down from last year.
  • According to the latest figures from FY2024, Therapeutics' Capital Expenditures is $122,000, which was down 89.16% from $1.1 million recorded in FY2023.
  • Therapeutics' 5-year Capital Expenditures high stood at $1.1 million for FY2023, and its period low was $122,000 during FY2024.
  • For the 3-year period, Therapeutics' Capital Expenditures averaged around $697,333, with its median value being $845,000 (2022).
  • Its Capital Expenditures has fluctuated over the past 5 years, first soared by 89.70% in 2021, then slumped by 89.16% in 2024.
  • Over the past 5 years, Therapeutics' Capital Expenditures (Yearly) stood at $398,000 in 2020, then spiked by 89.70% to $755,000 in 2021, then rose by 11.92% to $845,000 in 2022, then spiked by 33.14% to $1.1 million in 2023, then plummeted by 89.16% to $122,000 in 2024.